WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved JANUMET ® XR ...

(CNN) -- A widely-used diabetes drug has been recalled after manufacturers found it contained unacceptably high levels of a cancer-causing contaminant. Indian pharmaceutical company Marksans Pharma ...

Janumet™ (MK-0431A) combines two OADs with complementary mechanisms of action to improve glycemic control, sitagliptin and metformin. The tablet was designed in order to be bioequivalent to ...

Seamless reading experience. Save your favourite. The lot has been manufactured at Lupin's Mandideep (Madhya Pradesh) manufacturing facility, and then supplied to company's Baltimore-based arm, Lupin ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA on Monday approved the first oral therapy to ...

In Phase 3 studies, INVOKANA® plus metformin lowered blood sugar and reduced secondary endpoints of body weight and systolic blood pressure to a greater degree than metformin alone RARITAN, N.J, ...

Studies have shown that lack of adherence towards taking medicines as a major cause of diabetes related complications, hospitalization and deaths. DawaaDost, a retailer of affordable medicines has ...

BRIDGEWATER, N.J. — Amneal Pharmaceuticals is adding blackberry flavoring to a generic diabetes drug following feedback from customers, the company said Wednesday. Amneal announced the changes to its ...

The National Pharmaceutical Pricing Authority (NPPA) has notified the retail price of nine new drugs, including three anti-inflammation fixed dose combinations (FDCs) and six antidiabetic combinations ...

Zydus Lifesciences Ltd. (formerly known as Cadila Healthcare Ltd.), has received final approval from the United States Food and Drug Administration (USFDA) to market Empagliflozin and Metformin ...